| Literature DB >> 32677933 |
Atalay Mulu Fentie1, Tamir Birhanu Tadesse2, Gebremedhin Beedemariam Gebretekle3.
Abstract
BACKGROUND: Cervical cancer is the second most common cancer in Ethiopia next to breast cancer. Despite the high burden of the disease and availability of free screening services in Ethiopia, uptake is still trivial. This study aims to identify factors associated with cervical cancer screening uptake, VIA (visual inspection with acetic acid) positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.Entities:
Keywords: Cervical cancer; Screening uptake; VIA positivity; VIA test
Mesh:
Substances:
Year: 2020 PMID: 32677933 PMCID: PMC7366887 DOI: 10.1186/s12905-020-01008-3
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Fig. 1Flow chart of participant enrollment for the quantitative surveys
Socio-demographic and behavioral characteristics of women screened for cervical cancer, Addis Ababa, Ethiopia
| Variables, n = 844 | n(%) | Name of health center | ||||
|---|---|---|---|---|---|---|
| AH | W1H | SH | FMH | LH | ||
| Age (in years), | ||||||
| 15–24 | 54 (6.4) | 19 (12.7) | 9 (5.3) | 6 (3.1) | 9 (6.9) | 11 (5.5) |
| 25–34 | 343 (40.7) | 48 (32.0) | 70 (41.2) | 94 (48.2) | 55 (42.3) | 76 (38.2) |
| 35–45 | 359 (42.5) | 61 (40.7) | 69 (40.6) | 76 (39.0) | 61 (46.9) | 92 (46.2) |
| 46–55 | 77 (9.1) | 20 (13.3) | 19 (11.2) | 18 (9.2) | 3 (2.3) | 17 (8.6) |
| > 55 | 11 (1.3) | 2 (1.3) | 3 (1.7) | 1 (0.5) | 2 (1.6) | 3 (1.5) |
| Residence, | ||||||
| Addis Ababa (AA) | 841 (99.4) | 149 (99.3) | 170 (100.0) | 194 (99.5) | 130 (100.0) | 198 (99.5) |
| Outside AA | 3 (0.6) | 1 (0.7) | 0 (0) | 1 (0.5) | 0 (0) | 1 (0.5) |
| Marital status, | ||||||
| Single | 87 (10.3) | 30 (20.0) | 21 (12.4) | 12 (6.2) | 5 (3.8) | 19 (9.5) |
| Married | 696 (82.5) | 112 (74.7) | 141 (82.9) | 169 (86.6) | 111 (85.4) | 163 (81.9) |
| Divorced | 53 (6.3) | 8 (5.3) | 7 (4.1) | 12 (6.2) | 12 (9.2) | 14 (7.0) |
| Widowed | 8 (0.9) | 0 (0) | 1 (0.6) | 2 (1.0) | 2 (1.6) | 3 (1.6) |
| Ever habit of smoking, | ||||||
| Yes | 11 (1.3) | 3 (2.0) | 2 (1.2) | 3 (1.5) | 0 (0) | 3 (1.5) |
| No | 833 (98.7) | 147 (98.0) | 168 (98.8) | 192 (98.5) | 130 (100.0) | 196 (98.5) |
| Age at first sexual intercourse, | ||||||
| ≤ 15 | 174 (20.6) | 22 (14.7) | 21 (12.4) | 40 (20.5) | 17 (13.1) | 49 (24.6) |
| 16–24 | 584 (69.2) | 103 (68.7) | 97 (57.1) | 118 (60.5) | 68 (52.3) | 126 (63.3) |
| 25–34 | 81 (9.6) | 25 (16.6) | 51 (30.0) | 35 (17.9) | 45 (34.6) | 23 (11.6) |
| 35–44 | 5 (0.6) | 0 (0) | 1 (0.5) | 2 (1.1) | 0 (0) | 1 (0.5) |
| Life time sexual partners, | ||||||
| 1 | 287 (34.0) | 56 (37.3) | 74 (43.5) | 57 (29.2) | 52 (40.0) | 48 (24.1) |
| ≥ 2 | 557 (66.0) | 94 (62.7) | 96 (56.5) | 138 (70.8) | 78 (60.0) | 151 (75.9) |
| Previously screened for cervical cancer | ||||||
| Yes | 0 (0.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| No | 844 (100) | 150 (100) | 170 (100) | 195 (100) | 130 (100) | 199 (100) |
p-value is as per chi-square test done between demographic characteristics and health center type, AH Arada health center, W1H Woreda 1 health center, SH Selam health center, FH Felegemelese health center, LH Lideta health center.
Sexual and reproductive history of women screened for cervical cancer and proportion of VIA positivity, Addis Ababa, Ethiopia
| Variable, n = 844 | n(%) | Name of health center | ||||
|---|---|---|---|---|---|---|
| AH | W1H | SH | FMH | LH | ||
| Menstrual History, | ||||||
| Regularly | 382 (45.3) | 74 (49.3) | 77 (45.3) | 92 (47.2) | 57 (43.8) | 82 (41.2) |
| Irregular | 290 (34.4) | 49 (32.7) | 64 (37.6) | 63 (32.3) | 55 (42.3) | 59 (29.6) |
| Post coital spotting | 7 (0.8) | 0 (0) | 4 (2.4) | 1 (0.5) | 1 (0.8) | 1 (0.5) |
| Menopause | 165 (19.5) | 27 (18.0) | 25 (14.7) | 39 (20.0) | 17 (13.1) | 57 (28.6) |
| Pregnancy status, | ||||||
| Pregnant | 1 (0.1) | 0 (0) | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) |
| Non-pregnant | 843 (99.9) | 150 (100) | 170 (100) | 194 (99.5) | 130 (100) | 199 (100) |
| Parity, | ||||||
| No | 119 (14.1) | 31 (20.7) | 28 (16.5) | 25 (12.8) | 6 (4.6) | 29 (14.6) |
| 1–3 | 575 (68.1) | 89 (59.3) | 99 (58.2) | 136 (69.7) | 115 (88.5) | 136 (68.3) |
| 4–5 | 107 (12.7) | 24 (16.0) | 32 (18.8) | 21 (10.8) | 4 (3.1) | 26 (13.1) |
| > 5 | 43 (5.1) | 6 (4.0) | 11 (6.5) | 13 (6.7) | 5 (3.8) | 8 (4.0) |
| Ever use of contraceptive methods, | ||||||
| No | 561 (66.5) | 107 (71.3) | 117 (68.8) | 129 (66.2) | 69 (53.1) | 139 (69.8) |
| Yes | 283 (33.5) | 43 (28.7) | 53 (31.2) | 66 (33.8) | 61 (46.9) | 60 (30.2) |
| Type of contraceptive method, | ||||||
| Injectable | 86 (30.4) | 12 (27.9) | 14 (26.9) | 22 (33.3) | 20 (33.3) | 18 (30.0) |
| OCP | 42 (14.8) | 10 (23.4) | 8 (15.4) | 11 (16.7) | 5 (8.4) | 6 (10.0) |
| IUCD | 45 (15.9) | 8 (18.6) | 10 (19.2) | 11 (16.7) | 3 (5.0) | 13 (21.7) |
| Implant | 102 (36.0) | 11 (25.6) | 19 (36.5) | 19 (28.8) | 30 (50.0) | 23 (38.3) |
| Tubaligation | 1 (0.4) | 0 (0) | 0 (0) | 1 (1.5) | 0 (0) | 0 (0) |
| Condom | 7 (2.5) | 2 (4.5) | 1 (1.9) | 2 (3.0) | 2 (3.3) | 0 (0) |
| Other corticosteroid use history, | ||||||
| Yes | 2 (0.2) | 1 (0.7) | 0 (0) | 0 (0) | 1 (0.8) | 0 (0) |
| No | 842 (99.8) | 149 (99.3) | 170 (100) | 195 (100) | 129 (99.2) | 199 (100) |
| Family hx of cervical cancer, | ||||||
| Yes | 5 (0.6) | 2 (1.3) | 1 (0.6) | 1 (0.5) | 0 (0) | 1 (0.5) |
| No | 839 (99.4) | 148 (98.7) | 169 (99.4) | 194 (99.5) | 130 (100) | 198 (99.5) |
| HIV status, | ||||||
| HIV positive | 252 (29.9) | 64 (42.7) | 56 (32.9) | 35 (26.9) | 53 (27.2) | 46 (23.1) |
| HIV negative | 447 (53.0) | 47 (31.3) | 81 (47.6) | 48 (36.9) | 124 (63.6) | 146 (73.4) |
| Unknown | 145 (17.1) | 39 (26) | 33 (19.4) | 47 (36.2) | 18 (9.2) | 7 (3.5) |
| STI history | ||||||
| Yes | 247 (29.3) | 16 (10.7) | 44 (25.9) | 55 (28.2) | 65 (50.0) | 67 (33.7) |
| No | 597 (70.7) | 134 (89.3) | 126 (74.1) | 140 (71.8) | 65 (50.0) | 132 (66.3) |
| VIA test result, | ||||||
| Positive | 87 (10.3) | 8 (5.3)) | 8 (4.7) | 30 (25.4) | 11 (8.5)) | 30 (25.1) |
| Negative | 757 (89.7) | 142 (94.7 | 162 (95.3) | 165 (84.6) | 119 (91.5 | 169 (84.9) |
p-value is as per chi-square test done between sexual and reproductive characteristics; and health center type, AH Arada health center, W1H Woreda 1 health center, SH Selam health center, FH Felegemelese health center, LH Lideta health center, OCP Oral contraceptives, IUCD Intrauterine contraceptive device.
Univariate and multivariable logistic regression analysis results for predictors of VIA positivity among women screened for cervical lesion, Addis Ababa, Ethiopia
| Variable | Screening result, n (%) | COR (95%CI) | AOR (95%CI) | |
|---|---|---|---|---|
| Positive | Negative | |||
| Age (in years) | ||||
| ≤ 24 | 2 (2.3) | 52 (6.9) | 1.00 | 1.00 |
| 25–34 | 27 (31.0) | 316 (36.9) | 2.2 (0.5–9.6) | 2.4 (0.51–11.5) |
| 35–44 | 40 (46.0) | 319 (42.1) | 3.26 (0.77–13.9) | 3.8 (0.81–18.2) |
| 45–54 | 15 (17.2) | 62 (8.1) | 6.3 (1.4–28.8) | 8.1 (1.53–42.3) |
| ≥ 55 | 3 (3.5) | 8 (3.0) | 9.8 (1.4–67.7) | 8.4 (1.1–72.3) |
| Marital status | ||||
| Married | 62 (71.3) | 634 (83.8) | 1.00 | 1.00 |
| Single | 12 (13.8) | 75 (9.9) | 1.6 (0.8–3.2) | 3.2 (1.4–7.31) |
| Divorced | 8 (9.2) | 45 (5.9) | 1.8 (0.8–4.1) | 1.8 (0.76–4.27) |
| Widowed | 5 (5.7) | 3 (0.4) | 17.1 (4.1–72.9) | 18.6 (3.8–91.2) |
| Parity | ||||
| Null Para | 11 (12.6) | 108 (14.3) | 1.00 | 1.00 |
| Multi Para | 64 (73.6) | 568 (75.0) | 1.1 (0.56–2.2) | 1.7 (0.72–4.0) |
| Grand multi Para | 12 (13.8) | 81 (10.7) | 1.46 (0.61–3.5) | 1.9 (0.63–5.52) |
| Age at first sexual intercourse | ||||
| ≥ 16 years | 52 (59.8) | 617 (81.5) | 1.00 | 1.00 |
| < 16 years | 35 (40.2) | 140 (18.5) | 3.1 (1.86–4.73) | 2.72 (1.65–4.49) |
| Ever use of contraceptive | ||||
| No | 59 (67.8) | 502 (66.3) | 1.00 | 1.00 |
| Yes | 28 (32.2) | 255 (33.7) | 0.93 (0.58–1.51) | 0.64 (0.37–1.11) |
| Smoking habit history | ||||
| No | 86 (98.8) | 747 (98.7) | 1.00 | 1.00 |
| Yes | 1 (1.2) | 10 (11.3) | 0.88 (0.11–6.87) | 1.25 (0.13–11.8) |
| Lifetime number of sexual partners | ||||
| 1 | 15 (17.2) | 272 (35.9) | 1.00 | 1.00 |
| ≥ 2 | 72 (82.8) | 485 (64.1) | 5.6 (1.9–9.82) | 4.9 (1.31–8.75) |
| HIV status | ||||
| HIV negative | 34 (39.1) | 413 (54.6) | 1.00 | 1.00 |
| HIV positive | 44 (50.6) | 208 (27.5) | 2.57 (1.59–4.14) | 2.59 (1.56–4.25) |
| Unknown | 9 (10.3) | 136 (17.9) | 0.80 (0.38–1.72) | 0.88 (0.41–1.93) |
| STI history | ||||
| No | 65 (74.7) | 532 (70.3) | 1.00 | 1.00 |
| Yes | 22 (25.3) | 225 (29.7) | 0.8 (0.48–1.33) | 1.46 (0.84–2.53) |
| Between group variance | 0.245 (95%CI: 0.0446–1.247, | |||
| ICC | 0.069 | |||
ICC Intra-cluster correlation coefficient. The between group variance and ICC was computed to see VIA test positivity (dependent variable) variability among type of health center cluster s (independent variable) as per multilevel mixed effects models for logistic regression. ICC = 0.245/(0.245 + π2/3) = 0.245/3.535 = 0.069